These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 19849855)

  • 1. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
    Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
    Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
    Mikels AJ; Nusse R
    PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade.
    Golan T; Yaniv A; Bafico A; Liu G; Gazit A
    J Biol Chem; 2004 Apr; 279(15):14879-88. PubMed ID: 14747478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.
    Kim M; Lee HC; Tsedensodnom O; Hartley R; Lim YS; Yu E; Merle P; Wands JR
    J Hepatol; 2008 May; 48(5):780-91. PubMed ID: 18313787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration.
    Toyama T; Lee HC; Koga H; Wands JR; Kim M
    Mol Cancer Res; 2010 Feb; 8(2):254-65. PubMed ID: 20103596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts.
    Liu G; Bafico A; Aaronson SA
    Mol Cell Biol; 2005 May; 25(9):3475-82. PubMed ID: 15831454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/Frizzled signaling in hepatocellular carcinoma.
    Lee HC; Kim M; Wands JR
    Front Biosci; 2006 May; 11():1901-15. PubMed ID: 16368566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation.
    Davis EK; Zou Y; Ghosh A
    Neural Dev; 2008 Nov; 3():32. PubMed ID: 18986540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion.
    Tung EK; Wong BY; Yau TO; Ng IO
    PLoS One; 2012; 7(5):e36565. PubMed ID: 22570728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas.
    Mebarki S; Désert R; Sulpice L; Sicard M; Desille M; Canal F; Dubois-Pot Schneider H; Bergeat D; Turlin B; Bellaud P; Lavergne E; Le Guével R; Corlu A; Perret C; Coulouarn C; Clément B; Musso O
    Oncotarget; 2016 Jun; 7(26):39026-39043. PubMed ID: 27191501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast.
    Pollheimer J; Loregger T; Sonderegger S; Saleh L; Bauer S; Bilban M; Czerwenka K; Husslein P; Knöfler M
    Am J Pathol; 2006 Apr; 168(4):1134-47. PubMed ID: 16565489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation.
    Baksh D; Boland GM; Tuan RS
    J Cell Biochem; 2007 Aug; 101(5):1109-24. PubMed ID: 17546602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
    Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
    PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells.
    Lyons JP; Mueller UW; Ji H; Everett C; Fang X; Hsieh JC; Barth AM; McCrea PD
    Exp Cell Res; 2004 Aug; 298(2):369-87. PubMed ID: 15265686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin.
    Wei W; Chua MS; Grepper S; So SK
    Mol Cancer; 2011 Feb; 10():16. PubMed ID: 21314951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.